241 related articles for article (PubMed ID: 12777473)
1. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation.
Norlin M; von Bahr S; Bjorkhem I; Wikvall K
J Lipid Res; 2003 Aug; 44(8):1515-22. PubMed ID: 12777473
[TBL] [Abstract][Full Text] [Related]
2. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
[TBL] [Abstract][Full Text] [Related]
3. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Björkhem I; Hansson M
Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
[TBL] [Abstract][Full Text] [Related]
4. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits.
Honda A; Yoshida T; Xu G; Matsuzaki Y; Fukushima S; Tanaka N; Doy M; Shefer S; Salen G
Metabolism; 2004 Jan; 53(1):42-8. PubMed ID: 14681840
[TBL] [Abstract][Full Text] [Related]
5. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene.
Rosen H; Reshef A; Maeda N; Lippoldt A; Shpizen S; Triger L; Eggertsen G; Björkhem I; Leitersdorf E
J Biol Chem; 1998 Jun; 273(24):14805-12. PubMed ID: 9614081
[TBL] [Abstract][Full Text] [Related]
6. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.
Griffiths WJ; Crick PJ; Meljon A; Theofilopoulos S; Abdel-Khalik J; Yutuc E; Parker JE; Kelly DE; Kelly SL; Arenas E; Wang Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Feb; 1864(2):191-211. PubMed ID: 30471425
[TBL] [Abstract][Full Text] [Related]
7. 27-hydroxylated low density lipoprotein (LDL) cholesterol can be converted to 7alpha,27-dihydroxy-4-cholesten-3-one (cytosterone) before suppressing cholesterol production in normal human fibroblasts. Evidence that an altered metabolism of ldl cholesterol can underlie a defective feedback control in malignant cells.
Axelson M; Larsson O
J Biol Chem; 1996 May; 271(22):12724-36. PubMed ID: 8662693
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1).
von Bahr S; Movin T; Papadogiannakis N; Pikuleva I; Rönnow P; Diczfalusy U; Björkhem I
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1129-35. PubMed ID: 12117727
[TBL] [Abstract][Full Text] [Related]
9. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
10. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase.
Båvner A; Shafaati M; Hansson M; Olin M; Shpitzen S; Meiner V; Leitersdorf E; Björkhem I
J Lipid Res; 2010 Sep; 51(9):2722-30. PubMed ID: 20511491
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of a novel side chain modified Delta8(14)-15-ketosterol, a potential cholesterol lowering drug: 28-hydroxylation by CYP27A1.
Pettersson H; Norlin M; Andersson U; Pikuleva I; Björkhem I; Misharin AY; Wikvall K
Biochim Biophys Acta; 2008 Aug; 1781(8):383-90. PubMed ID: 18603016
[TBL] [Abstract][Full Text] [Related]
14. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors.
Oftebro H; Björkhem I; Størmer FC; Pedersen JI
J Lipid Res; 1981 May; 22(4):632-40. PubMed ID: 6792308
[TBL] [Abstract][Full Text] [Related]
15. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
16. 24-hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A).
Norlin M; Toll A; Björkhem I; Wikvall K
J Lipid Res; 2000 Oct; 41(10):1629-39. PubMed ID: 11013305
[TBL] [Abstract][Full Text] [Related]
17. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways.
Pikuleva IA; Babiker A; Waterman MR; Björkhem I
J Biol Chem; 1998 Jul; 273(29):18153-60. PubMed ID: 9660774
[TBL] [Abstract][Full Text] [Related]
18. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
Buchmann MS; Björkhem I; Lund AM; Skrede S
Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
[TBL] [Abstract][Full Text] [Related]
19. Cerebrotendinous xanthomatosis.
Björkhem I
Curr Opin Lipidol; 2013 Aug; 24(4):283-7. PubMed ID: 23759795
[TBL] [Abstract][Full Text] [Related]
20. Assay method for mitochondrial sterol 27-hydroxylase with 7alpha-hydroxy-4-cholesten-3-one as a substrate in the rat liver.
Ota Y; Eto TA; Tanaka S; Sueta H; Shiotsuki H; Maeda Y; Une M; Chijiiwa K
J Lipid Res; 2003 Dec; 44(12):2400-5. PubMed ID: 12951370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
